NCT01467011View on ClinicalTrials.gov

Myfortic, Prograf, and Corticosteroids in de Novo Liver Transplantation

CompletedOBSERVATIONAL

Enrollment

25

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions

End Stage Liver Disease

Interventions

DRUG

Enteric-coated Mycophenolate Sodium

1440mg/day for 6 months posttransplant

Trial Locations (1)

77030

The Methodist Hospital System, Houston

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Novartis

INDUSTRY

lead

R. Mark Ghobrial, MD

OTHER